Loop Insights (TSXV: MTRX) (OTCQB: RACMF), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement and automated venue tracing to the brick-and-mortar space, today announced its collaboration with bdG Sports. According to the update, Loop Insights was selected by bdG to provide its venue management platform to the…
Sustainable Green Team (OTC: SGTM) is a leading provider of beneficial solutions for tree and storm waste disposal. SGTM’s solutions are designed to alleviate environmental burdens that have traditionally afflicted landfills and disposal sites around the country. Throughout its 40-year tenure, SGTM has prided itself in building a reputation as an environmentally responsible enterprise, focused…
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has appointed Claudia Rimerman Kraut in the newly created role of vice president of broker and consultant partnerships. Kraut comes to her new responsibilities with impressive senior-management experience at Omada Health, American Well, AIG, United Healthcare and Humana. Kraut will lead Dario’s benefit consultant and…
AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of nonsystemic, recombinant therapies for gastrointestinal diseases, will be participating in the upcoming Biotech Showcase Digital 2021 conference. The multiday event is scheduled for Jan. 11–15, 2021. As part of the company’s planned participation, AzurRx president and CEO James Sapirstein, along with other members of the senior management team,…
Loop Insights (TSX.V: MTRX) (OTCQB: RACMF), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement, and automated venue tracing to the brick-and-mortar space, has named Danny M Spataro as its new director of sales, sports and entertainment; the appointment takes effect Jan. 11, 2021, and is designed to…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that its CEO, John Climaco, will present at the virtual H.C. Wainwright BioConnect 2021 Conference. The event is slated to be held from Jan. 11-14, 2021, with…
Cybin (NEO: CYBN), a life sciences company focused on psychedelic pharmaceutical therapies, has provided an update on its patent filings. The company has eight filings, all tied to Cybin’s novel therapeutics, delivery mechanisms and treatment regiments. The patent updates noted that Cybin has patent applications for the following: a provisional patent application for an oral…
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that its wholly owned subsidiary Helomics has completed the integration of Quantitative Medicine’s (“QM”) novel active-learning Computational Research Engine (CoRE(TM)). According to the update, CoRE was integrated with Helomics’ proprietary TumorSpace(TM) knowledgebase of 150,000…
iClick Interactive (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, has launched a powerful off-the-shelf (standard) SaaS enterprise management platform. Called iSCRM, the platform is designed for daily operations and social customer relationship management. iSCRM helps customers attract new users and manage private traffic through leveraging updated features and various functions on…
VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, today announced its receipt of notice from The Nasdaq Stock Market on Jan. 5, 2021, that VistaGen has regained compliance with the minimum bid price requirement. The requirement is under Nasdaq Listing Rule 5550(a)(2) (the…
AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of targeted, non-systemic therapies for gastrointestinal (“GI”) diseases, today announced that it will participate in the virtual H.C. Wainwright BioConnect Conference taking place on Jan. 11-14, 2021. According to the update, AzurRx BioPharma president and CEO James Sapirstein will take part in virtual one-on-one meetings with…
180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company with its lead indication in phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced that it will present at the H.C. Wainwright Bioconnect 2021 Conference. According to the update, the presentation will be available…
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has announced that it has hired an investor relations firm. POAI has chosen Landon Capital to provide investor relations services; the agreement was effective Dec. 30, 2020. The announcement noted that anticipated services would include introductions to…
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has been selected by a subsidiary of a U.S.-based Fortune 500 technology and engineering company to provide its digital therapeutics solution to eligible employees. DarioHealth’s partnership with Vitality Group made this agreement possible, which is DarioHealth’s first client in the self-insured employer market. One…
AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of nonsystemic, recombinant therapies for gastrointestinal diseases, will be participating in the 10th annual LifeSci Partners Corporate Access Event. As part of the company’s participation, AzurRx president and CEO James Sapirstein will present a summary of the company’s business and clinical-development programs to any interested parties. His presentation will…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, recently hosted a webinar to discuss the clinical design for its upcoming Phase 2 trial. The trial will study its lead drug candidate, Berubicin, for the treatment of glioblastoma…
Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has announced its entry into another contract in Arizona. According to NRF, organized retail crime (“ORC”) costs the retail industry approximately $30 billion each year, and preparation is a key factor in prevention. A Phoenix, Arizona-based shopping center has elected to…
iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, today announced the addition of Philip Kan to its board of directors, effective Jan. 1, 2021. Per the update, Kan will chair iClick’s Nominating and Corporate Governance Committee. “The addition of Philip to the board will help bring…
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a leading producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, today announced that its subsidiary, Xunpusen Technology Co. Ltd., generated approximately RMB30 million (approximately USD $4.5 million) in revenue in the first four months of operation. According to the…
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights to publicly traded companies through its software-as-a-service (“SaaS”) platform, Sequire, today announced that Lou Kerner will be appointed chief executive officer of its wholly owned subsidiary BIGtoken. SRAX previously announced its entry into a definitive agreement with Force Protection Video Equipment Corp (OTC:…